Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry.

Su WC, Chen YC, Tseng CH, Hsu PW, Tung KF, Jeng KS, Lai MM.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17516-21. doi: 10.1073/pnas.1312374110. Epub 2013 Oct 7.

2.

Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.

Edinger TO, Pohl MO, Yángüez E, Stertz S.

MBio. 2015 Jun 9;6(3):e00297. doi: 10.1128/mBio.00297-15.

3.

Interaction of NS2 with AIMP2 facilitates the switch from ubiquitination to SUMOylation of M1 in influenza A virus-infected cells.

Gao S, Wu J, Liu RY, Li J, Song L, Teng Y, Sheng C, Liu D, Yao C, Chen H, Jiang W, Chen S, Huang W.

J Virol. 2015 Jan;89(1):300-11. doi: 10.1128/JVI.02170-14. Epub 2014 Oct 15.

4.

Prolidase is required for early trafficking events during influenza A virus entry.

Pohl MO, Edinger TO, Stertz S.

J Virol. 2014 Oct;88(19):11271-83. doi: 10.1128/JVI.00800-14. Epub 2014 Jul 16.

5.

A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.

Hsu SF, Su WC, Jeng KS, Lai MM.

J Virol. 2015 Apr;89(7):3671-82. doi: 10.1128/JVI.03610-14. Epub 2015 Jan 14.

6.

The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43.

Nailwal H, Sharma S, Mayank AK, Lal SK.

Cell Death Dis. 2015 May 21;6:e1768. doi: 10.1038/cddis.2015.131.

7.

Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration.

Stauffer S, Feng Y, Nebioglu F, Heilig R, Picotti P, Helenius A.

J Virol. 2014 Nov;88(22):13029-46. doi: 10.1128/JVI.01430-14. Epub 2014 Aug 27.

8.

TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection.

Patil G, Zhao M, Song K, Hao W, Bouchereau D, Wang L, Li S.

J Virol. 2018 Jul 31;92(16). pii: e00905-18. doi: 10.1128/JVI.00905-18. Print 2018 Aug 15.

PMID:
29899090
9.

A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.

Su WC, Hsu SF, Lee YY, Jeng KS, Lai MM.

J Virol. 2015 Nov;89(22):11245-55. doi: 10.1128/JVI.01487-15. Epub 2015 Aug 26.

10.

CNOT4-Mediated Ubiquitination of Influenza A Virus Nucleoprotein Promotes Viral RNA Replication.

Lin YC, Jeng KS, Lai MMC.

MBio. 2017 May 23;8(3). pii: e00597-17. doi: 10.1128/mBio.00597-17.

11.

The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.

Liu B, Li NL, Shen Y, Bao X, Fabrizio T, Elbahesh H, Webby RJ, Li K.

J Virol. 2016 Apr 14;90(9):4369-4382. doi: 10.1128/JVI.03172-15. Print 2016 May.

12.

Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles.

Su WC, Yu WY, Huang SH, Lai MMC.

J Virol. 2018 Jan 30;92(4). pii: e01972-17. doi: 10.1128/JVI.01972-17. Print 2018 Feb 15.

13.

The Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation.

Lee CP, Liu GT, Kung HN, Liu PT, Liao YT, Chow LP, Chang LS, Chang YH, Chang CW, Shu WC, Angers A, Farina A, Lin SF, Tsai CH, Bouamr F, Chen MR.

J Virol. 2016 Sep 29;90(20):8994-9007. doi: 10.1128/JVI.01235-16. Print 2016 Oct 15.

14.

Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch.

Jadwin JA, Rudd V, Sette P, Challa S, Bouamr F.

J Virol. 2010 Jan;84(2):704-15. doi: 10.1128/JVI.01319-09. Epub 2009 Oct 28.

15.

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Mäurer AP, Müller E, Wolff T, Rudel T, Meyer TF.

Nature. 2010 Feb 11;463(7282):818-22. doi: 10.1038/nature08760. Epub 2010 Jan 17.

PMID:
20081832
16.

Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.

Chen SC, Jeng KS, Lai MMC.

J Virol. 2017 Sep 27;91(20). pii: e00842-17. doi: 10.1128/JVI.00842-17. Print 2017 Oct 15.

17.

Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses.

Elbahesh H, Cline T, Baranovich T, Govorkova EA, Schultz-Cherry S, Russell CJ.

J Virol. 2014 Jun;88(12):6714-28. doi: 10.1128/JVI.00530-14. Epub 2014 Apr 2.

18.

Ubiquitin in Influenza Virus Entry and Innate Immunity.

Rudnicka A, Yamauchi Y.

Viruses. 2016 Oct 24;8(10). pii: E293. Review.

19.

Human host factors required for influenza virus replication.

König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK.

Nature. 2010 Feb 11;463(7282):813-7. doi: 10.1038/nature08699.

20.

Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation.

Musiol A, Gran S, Ehrhardt C, Ludwig S, Grewal T, Gerke V, Rescher U.

MBio. 2013 Nov 5;4(6):e00608-13. doi: 10.1128/mBio.00608-13.

Supplemental Content

Support Center